Internet of Things (IoT) plays a significant role in clinical trials in terms of regulatory authorisations, post-marketing trials, clinical trial data collection, patient recruitment, and more.
IoT offers opportunities for the expansion of consumer-oriented Internet-connected devices such as wearables and smartphones, as well as value-added health services for the diagnosis and treatment of diseases. Combining IoT technology with clinical trial processes can reduce the expenses of clinical research and help in inventing and validating new medical products and services.
Discover the leading clinical trial IoT companies
Clinical Trials Arena has listed some of the leading companies offering products and services related to IoT using its intel, insights and decades-long experience in the sector.
The information provided in the download document is drafted for clinical trial executives and technology leaders involved in cloud innovations.
The download contains detailed information on suppliers and their product offerings, as well as contact details to aid purchasing or hiring decisions.
Among the leading suppliers of IoT for clinical trials are Medidata, Medable, Science 37, KORE Wireless, CSL Behring, Haleon, Precision Digital Health, Avantor, Novapeutics, and IQVIA.
Applications of IoT in clinical trials
Unlike obtaining static data from a clinical study, IoT technology can allow the dynamic acquisition and processing of data from patients along with data processing and analytics services. IoT in clinical trials helps in increasing accuracy, reducing patient risks, and improving patient recruitment.
IoT may help in creating new possibilities for uploading health data from medical devices such as blood pressure monitors to websites. The enormous health data collected through IoT can offer more information than earlier to both patients and healthcare professionals. The data allows healthcare professionals to provide patient-appropriate feedback based on insights from the data.
Role of IoT in virtual clinical trials
Adoption of virtual trials in wake of the Covid-19 pandemic will have a long-term influence on mobile and IoT-based wearables. The rising investments in remote patient monitoring can completely transform the on-site environment into virtual trials with benefits such as larger sample size, reduced medical staff, enhanced data quality, stay-at-home trials, patient safety monitoring, risk-based real-time monitoring, and reduced site setup and costs.
Remote patient monitoring is enabled by consumer-oriented IoT devices. The state-of-the-art IoT devices support contract research organisations in real-time data collection and processing. They also help in providing alerts and notification triggers, remote screening, and periodic self-assessments of study participants through connected digital devices.